ADAM19 and ovarian cancer: In addition, repression of ADAM19, a SMAD target gene, has been associated with the repressive histone modifications, H3K27me3 and H3K9me2, and histone deacetylase in ovarian cancer cells, while the promoter of ADAM19 was unmethylated [52].